<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>BIO Asia-Taiwan</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Taiwan's government embraces biotech startups, but need for capital, greater visibility remain</title>
      <description>
        <![CDATA[Growing the international competitiveness of Taiwan’s biotech sector is one of six key strategies Taiwan’s government is heavily invested in, Taiwan President Tsai Ing-wen told attendees via video during the recent BIO Asia-Taiwan conference in Taipei.]]>
      </description>
      <guid>http://www.bioworld.com/articles/521826</guid>
      <pubDate>Tue, 23 Aug 2022 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/521826-taiwans-government-embraces-biotech-startups-but-need-for-capital-greater-visibility-remain</link>
    </item>
    <item>
      <title>Taiwan's government embraces biotech startups, but need for capital, greater visibility remains</title>
      <description>
        <![CDATA[Growing the international competitiveness of Taiwan’s biotech sector is one of six key strategies Taiwan’s government is heavily invested in, Taiwan President Tsai Ing-wen told attendees via video during the recent BIO Asia-Taiwan conference in Taipei.]]>
      </description>
      <guid>http://www.bioworld.com/articles/521696</guid>
      <pubDate>Wed, 17 Aug 2022 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/521696-taiwans-government-embraces-biotech-startups-but-need-for-capital-greater-visibility-remains</link>
    </item>
    <item>
      <title>Big pharma looks to Taiwan for precision medicine partnerships </title>
      <description>
        <![CDATA[Big pharma is increasingly turning to Taiwan to leverage the power of the country’s data and computing power as precision medicine takes center stage in drug development, speakers said during the recent BIO Asia-Taiwan conference in Taipei.]]>
      </description>
      <guid>http://www.bioworld.com/articles/521239</guid>
      <pubDate>Tue, 02 Aug 2022 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/521239-big-pharma-looks-to-taiwan-for-precision-medicine-partnerships</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/Asia/Asia-night-space-Japan-China-Taiwan-Hong-Kong.webp?t=1594327416" type="image/png" medium="image" fileSize="1987676">
        <media:title type="plain">Asia at night from space</media:title>
      </media:content>
    </item>
    <item>
      <title>Taiwan can help biopharma use data more smartly to keep innovation moving </title>
      <description>
        <![CDATA[Keeping innovation growing at a fast clip while retaining new global supply chain capacity built up during the pandemic were the main topics of discussion at the Bio Asia-Taiwan conference July 27 in Taipei. With the theme of the conference, “Connecting the Asia Value Chain,” Taiwan Vice President Ching-Te Lai said the pandemic has demonstrated Taiwan’s resilience as well as the strength of the global biopharma industry.]]>
      </description>
      <guid>http://www.bioworld.com/articles/521221</guid>
      <pubDate>Tue, 02 Aug 2022 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/521221-taiwan-can-help-biopharma-use-data-more-smartly-to-keep-innovation-moving</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/AI/AI-silhouette.webp?t=1597864591" type="image/png" medium="image" fileSize="459689">
        <media:title type="plain">AI silhouette</media:title>
      </media:content>
    </item>
    <item>
      <title>Taiwan can help biopharma use data more smartly to keep innovation moving </title>
      <description>
        <![CDATA[Keeping innovation growing at a fast clip while retaining new global supply chain capacity built up during the pandemic were the main topics of discussion at the Bio Asia-Taiwan conference July 27 in Taipei. With the theme of the conference, “Connecting the Asia Value Chain,” Taiwan Vice President Ching-Te Lai said the pandemic has demonstrated Taiwan’s resilience as well as the strength of the global biopharma industry.]]>
      </description>
      <guid>http://www.bioworld.com/articles/521121</guid>
      <pubDate>Thu, 28 Jul 2022 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/521121-taiwan-can-help-biopharma-use-data-more-smartly-to-keep-innovation-moving</link>
    </item>
    <item>
      <title>BIO Asia-Taiwan: Cell and gene therapy development changing biopharma ecosystem</title>
      <description>
        <![CDATA[Cell and gene therapy have seen much progress in recent times, with the product pipelines in those areas bursting with more than 1,200 therapies. Naturally, the challenges, opportunities and essential development strategies in those fields were the focus on the last day of the BIO Asia-Taiwan Conference 2021.]]>
      </description>
      <guid>http://www.bioworld.com/articles/509780</guid>
      <pubDate>Tue, 27 Jul 2021 15:35:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/509780-bio-asia-taiwan-cell-and-gene-therapy-development-changing-biopharma-ecosystem</link>
    </item>
    <item>
      <title>BIO Asia-Taiwan Conference 2021 brings the promise of Asian market under spotlight</title>
      <description>
        <![CDATA[The biotech industry in Asia is a promising market, but it still has a long way to go to narrow the gap between Asian and Western markets, according to speakers on day two of the BIO Asia-Taiwan Conference 2021.]]>
      </description>
      <guid>http://www.bioworld.com/articles/509779</guid>
      <pubDate>Tue, 27 Jul 2021 15:32:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/509779-bio-asia-taiwan-conference-2021-brings-the-promise-of-asian-market-under-spotlight</link>
    </item>
    <item>
      <title>BIO Asia-Taiwan 2021 looks at financing strategies booming market</title>
      <description>
        <![CDATA[Financing is the fuel that drives growth in the biopharma sector, and participants at the BIO Asia-Taiwan Conference 2021 this week discussed different financing strategies for companies in the currently booming market.]]>
      </description>
      <guid>http://www.bioworld.com/articles/509778</guid>
      <pubDate>Tue, 27 Jul 2021 15:23:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/509778-bio-asia-taiwan-2021-looks-at-financing-strategies-booming-market</link>
    </item>
    <item>
      <title>BIO Asia-Taiwan: Cell and gene therapy development changing biopharma ecosystem</title>
      <description>
        <![CDATA[Cell and gene therapy have seen much progress in recent times, with the product pipelines in those areas bursting with more than 1,200 therapies. Naturally, the challenges, opportunities and essential development strategies in those fields were the focus on the last day of the BIO Asia-Taiwan Conference 2021.]]>
      </description>
      <guid>http://www.bioworld.com/articles/509676</guid>
      <pubDate>Fri, 23 Jul 2021 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/509676-bio-asia-taiwan-cell-and-gene-therapy-development-changing-biopharma-ecosystem</link>
    </item>
    <item>
      <title>BIO Asia-Taiwan Conference 2021 brings the promise of Asian market under spotlight</title>
      <description>
        <![CDATA[The biotech industry in Asia is a promising market, but it still has a long way to go to narrow the gap between Asian and Western markets, according to speakers on day two of the BIO Asia-Taiwan Conference 2021.]]>
      </description>
      <guid>http://www.bioworld.com/articles/509626</guid>
      <pubDate>Thu, 22 Jul 2021 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/509626-bio-asia-taiwan-conference-2021-brings-the-promise-of-asian-market-under-spotlight</link>
    </item>
    <item>
      <title>BIO Asia-Taiwan 2021 looks at financing strategies booming market</title>
      <description>
        <![CDATA[Financing is the fuel that drives growth in the biopharma sector, and participants at the BIO Asia-Taiwan Conference 2021 this week discussed different financing strategies for companies in the currently booming market.]]>
      </description>
      <guid>http://www.bioworld.com/articles/509582</guid>
      <pubDate>Wed, 21 Jul 2021 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/509582-bio-asia-taiwan-2021-looks-at-financing-strategies-booming-market</link>
    </item>
    <item>
      <title>Emerging biotechs remain major driver for global innovation</title>
      <description>
        <![CDATA[Emerging companies continue to have a bigger role in pushing biotech innovation, and their presence is more important than ever, given the race for a COVID-19 solution. Those companies’ role in global R&D and new drug approvals was stressed by experts at the current BIO Asia-Taiwan conference.]]>
      </description>
      <guid>http://www.bioworld.com/articles/496302</guid>
      <pubDate>Tue, 28 Jul 2020 16:43:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/496302-emerging-biotechs-remain-major-driver-for-global-innovation</link>
    </item>
    <item>
      <title>Boosted by COVID-19 success, Taiwan life sciences sector building government, investor support</title>
      <description>
        <![CDATA[With no new cases reported for more than 100 days, Taiwan appears to have successfully contained the spread of COVID-19 and has drawn attention to its medical achievements.]]>
      </description>
      <guid>http://www.bioworld.com/articles/496301</guid>
      <pubDate>Tue, 28 Jul 2020 16:39:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/496301-boosted-by-covid-19-success-taiwan-life-sciences-sector-building-government-investor-support</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/Asia/Asia-night-space-Japan-China-Taiwan-Hong-Kong.webp?t=1594327416" type="image/png" medium="image" fileSize="1987676">
        <media:title type="plain">Asia at night from space</media:title>
      </media:content>
    </item>
    <item>
      <title>Local vs. global: COVID-19 highlights supply chain debate among industry challenges</title>
      <description>
        <![CDATA[In the shadow of COVID-19, experts at the BIO Asia-Taiwan conference on Wednesday warned of present and future challenges for the biotech industry. Changes in manufacturing logistics and financial distress will continue to cause concern for the industry.]]>
      </description>
      <guid>http://www.bioworld.com/articles/496295</guid>
      <pubDate>Tue, 28 Jul 2020 16:25:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/496295-local-vs-global-covid-19-highlights-supply-chain-debate-among-industry-challenges</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Infectious/Antibodies-attacking-SARS-CoV-2-virus.webp?t=1640705029" type="image/png" medium="image" fileSize="425318">
        <media:title type="plain">Antibodies attacking SARS-CoV-2 virus</media:title>
      </media:content>
    </item>
    <item>
      <title>Boosted by COVID-19 success, Taiwan life sciences sector building government, investor support</title>
      <description>
        <![CDATA[With no new cases reported for more than 100 days, Taiwan appears to have successfully contained the spread of COVID-19 and has drawn attention to its medical achievements. Experts said at BIO Asia-Taiwan conference this week that with continuous government and investor support, the East Asian nation could move further up to join other leading biotech players.]]>
      </description>
      <guid>http://www.bioworld.com/articles/496228</guid>
      <pubDate>Fri, 24 Jul 2020 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/496228-boosted-by-covid-19-success-taiwan-life-sciences-sector-building-government-investor-support</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/Asia/Asia-night-space-Japan-China-Taiwan-Hong-Kong.webp?t=1594327416" type="image/png" medium="image" fileSize="1987676">
        <media:title type="plain">Asia at night from space</media:title>
      </media:content>
    </item>
    <item>
      <title>Local vs. global: COVID-19 highlights supply chain debate among industry challenges</title>
      <description>
        <![CDATA[In the shadow of COVID-19, experts at the BIO Asia-Taiwan conference on Wednesday warned of present and future challenges for the biotech industry. Changes in manufacturing logistics and financial distress will continue to cause concern for the industry.]]>
      </description>
      <guid>http://www.bioworld.com/articles/496197</guid>
      <pubDate>Thu, 23 Jul 2020 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/496197-local-vs-global-covid-19-highlights-supply-chain-debate-among-industry-challenges</link>
    </item>
    <item>
      <title>Emerging biotechs remain major driver for global innovation</title>
      <description>
        <![CDATA[Emerging companies continue to have a bigger role in pushing biotech innovation, and their presence is more important than ever, given the race for a COVID-19 solution. Those companies’ role in global R&D and new drug approvals was stressed by experts at the current BIO Asia-Taiwan conference.]]>
      </description>
      <guid>http://www.bioworld.com/articles/480372</guid>
      <pubDate>Wed, 22 Jul 2020 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/480372-emerging-biotechs-remain-major-driver-for-global-innovation</link>
    </item>
    <item>
      <title>Biopharma investments set to drop in 2019, but deal flow to stay strong: experts</title>
      <description>
        <![CDATA[TAIPEI, Taiwan – Asian capital continues to play a key role in funding biotech development regionally and globally through private investments, M&A deals or IPOs. And 2018 was a particularly exciting one for cross-border investments and health care IPOs, said speakers at the BIO Asia conference. The total deal value of global biopharma IPOs and M&A deals hit a record $49 billion in 2018.]]>
      </description>
      <guid>http://www.bioworld.com/articles/340205</guid>
      <pubDate>Mon, 29 Jul 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/340205-biopharma-investments-set-to-drop-in-2019-but-deal-flow-to-stay-strong-experts</link>
    </item>
    <item>
      <title>Regional, local collaborations essential to addressing unmet needs for Asian patients</title>
      <description>
        <![CDATA[TAIPEI, Taiwan – Western pharma players might not be addressing diseases that are specific to or predominant in Asia, speakers said on the second day of the BIO Asia-Taiwan conference, making regional collaboration important for developing therapeutics targeting unmet needs at home.]]>
      </description>
      <guid>http://www.bioworld.com/articles/381928</guid>
      <pubDate>Fri, 26 Jul 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/381928-regional-local-collaborations-essential-to-addressing-unmet-needs-for-asian-patients</link>
    </item>
    <item>
      <title>Asia needs to go beyond capital, talent, patient pool to nurture growing biotech ecosystem</title>
      <description>
        <![CDATA[TAIPEI, Taiwan – The three-day 2019 BIO Asia-Taiwan Conference and Exhibition opened on Wednesday to discuss how biotechnology could be the next growth engine for Asia. While figures are suggesting Asia is rising as a biotech powerhouse, the region needs to think beyond just capital, talent and patient pool, speakers said.]]>
      </description>
      <guid>http://www.bioworld.com/articles/353303</guid>
      <pubDate>Thu, 25 Jul 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/353303-asia-needs-to-go-beyond-capital-talent-patient-pool-to-nurture-growing-biotech-ecosystem</link>
    </item>
  </channel>
</rss>
